Intelligent Bio Solutions posts investor presentation on fingerprint sweat drug testing system

Reuters2026/08/28 13:13

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Intelligent Bio Solutions published an investor presentation outlining its fingerprint-sweat drug screening system, positioned as a rapid, non-invasive workplace testing alternative.
U.S. regulatory path centered on an FDA 510(k) submission for codeine targeted for Q4 2026, following additional-data requests in September 2025.
Plan assumes potential 510(k) clearance in H1 2027, followed by U.S. distribution buildout, faster cartridge development, expanded drug indications.
Reported FY 2026 revenue of USD 4.21 million, up 38% year over year; gross margin of 65%.
Disclosed 500+ active customer accounts across 35 countries and territories, supported by a consumables-led recurring revenue model tied to cartridge sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Intelligent Bio Solutions posts investor presentation on fingerprint sweat drug testing system

You may also like

Crypto prices